JP5396125B2 - Film-forming formulation - Google Patents
Film-forming formulation Download PDFInfo
- Publication number
- JP5396125B2 JP5396125B2 JP2009083355A JP2009083355A JP5396125B2 JP 5396125 B2 JP5396125 B2 JP 5396125B2 JP 2009083355 A JP2009083355 A JP 2009083355A JP 2009083355 A JP2009083355 A JP 2009083355A JP 5396125 B2 JP5396125 B2 JP 5396125B2
- Authority
- JP
- Japan
- Prior art keywords
- film
- skin
- oil
- water
- rosin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Medicinal Preparation (AREA)
Description
本発明は、外用製剤である被膜形成型製剤に関するものである。 The present invention relates to a film-forming preparation that is an external preparation.
従来の被膜形成型製剤は皮膚上にフィルムを形成するもので、本出願人は既に下記の特許文献1として提供している。この先行技術は、含有薬物の患部への経皮吸収性を改善し、局所の治療効果を高め、更に患部を皮膜で保護することによって外部からの物理的、化学的刺激や細菌感染を防ぎ、薬物の上に皮膚組織に近い膜を必要な皮膚上に形成するフィルム製剤を提供するもので、構成はニトロセルロースを、酢酸3−メチルブチル、酢酸イソブチル、又はアセトン、或いは、これらの混合物に溶解し、更にエチルアルコールを添加した溶解剤に薬効を主目的とする薬物を加え、塗布部位の皮膚上に透明或いは半透明のフィルムを形成することにより患部を密封するようにしたものである。
The conventional film-forming preparation forms a film on the skin, and the present applicant has already provided
ところで、先行技術の被膜形成型製剤は、被膜形成時に有機溶剤の気化時に皮膚角質層の水分を含む保湿成分を同時に揮散、或いは離脱させるために皮膚上に被膜を形成するものの皮膚の損傷(肌荒れ)を残し、被膜除去後の皮膚の再生に影響を与え、更に損傷皮膚の状態によっては非常に痛みを伴うという問題点があり、持続して繰り返し使用するのに大きな難点があるのが一般的な認識であった。この問題点を解消するには皮膚、特に皮膚角質層の保湿成分を喪失することなく、逆に水分を添加して角質層の保湿機能を高めることが解決手段になるものと考え、種々の保湿剤を添加することを試みた。 By the way, the film-forming preparation of the prior art forms a film on the skin in order to volatilize or release the moisture retaining component including moisture in the skin stratum corneum at the time of vaporization of the organic solvent at the time of film formation. ), Which affects the regeneration of the skin after removal of the film, and is also very painful depending on the condition of the damaged skin. It is generally difficult to use repeatedly for a long time. It was a real recognition. To solve this problem, we believe that adding moisture to improve the moisture retention function of the stratum corneum without losing the moisture retention component of the skin, especially the skin stratum corneum, is a solution. An attempt was made to add the agent.
しかしながら製皮膜形成製剤の有機溶剤揮散後に皮膚上に十分な被膜が形成されず、且つ形成後の被膜も非常に耐水性が弱く、水を使用する生活習慣の中で持続的に被膜の強度を維持することが非常に難しく、且つ形成被膜が皮膚上においてランダムに細剥離を繰り返すことから、時に皮膚表面と衣服更に生活空間の清潔度を極度に悪くするのが現状である。 However, a sufficient film is not formed on the skin after volatilization of the organic solvent of the film-forming preparation, and the film after the formation is very weak in water resistance, and the strength of the film is continuously maintained in the lifestyle using water. At present, it is extremely difficult to maintain, and since the formed coating repeats fine peeling at random on the skin, the cleanliness of the skin surface, clothes, and living space is sometimes extremely deteriorated.
被膜形成型製剤は従来の軟膏、クリーム、ジェルといった半固形製剤やローションに類する外用液剤に比較して塗布後の薬効の確実性と持続性、衣服や肌を汚さないといった清潔度、入浴時にも薬剤が取れないといった便利性に優れた製剤といえる。又、製剤形を有するプラスター剤、パップ剤、硬膏剤に比較して被膜形成型製剤は投与が簡便であり、使用後に薬剤を剥離・除去する必要性も無く、従って医療廃棄物を殆ど出さずに地球環境にやさしいといった特徴を有する。さらに外用製剤特有のかぶれ、発赤、浮腫といった皮膚障害の発生頻度が極めて低いのが特徴である。
しかしながら、本製剤は被膜形成時に有機溶剤を揮散させるために、揮散時に皮膚角質層の水分を含む保湿成分を同時に奪ってしまうという特徴を有する。この現象は長期使用する条件下では被膜除去後の皮膚に肌荒れ、皮膚割れといった皮膚損傷とそれに伴う痛みといったダメージを与えるのである。
本発明の課題は、被膜形成型製剤の被膜形成時の肌に、ダメージを与えずに患部を被覆し、表面が適度粘着性を有するする被膜形成型製剤を提供することにある。
Film-forming preparations are more reliable and durable after application than semi-solid preparations such as conventional ointments, creams and gels, and external liquids similar to lotions, cleanliness that does not stain clothes and skin, and even when taking a bath It can be said that it is a formulation with excellent convenience that the drug cannot be taken. In addition, the film-forming preparations are easier to administer than plasters, poultices, and plasters, and there is no need to peel off or remove the drugs after use, so there is almost no medical waste. It is characterized by being friendly to the global environment. Furthermore, the frequency of occurrence of skin disorders such as rash, redness, and edema peculiar to external preparations is very low.
However, since this preparation volatilizes an organic solvent at the time of film formation, it has a feature that it simultaneously deprives moisturizing components including moisture in the skin stratum corneum during volatilization. This phenomenon causes skin damage such as rough skin and cracking of the skin after the removal of the film under long-term use conditions, and damage such as pain associated therewith.
The subject of this invention is providing the film formation type formulation which coat | covers an affected part without giving damage to the skin at the time of film formation of a film formation type formulation, and the surface has moderate adhesiveness.
本発明者は従来の被膜形成製剤の塗布部に被膜を瞬時に形成し、患部を形成被膜で保護する特性と含有薬物の効果を落とさずに、副作用といえる塗布部位の皮膚に対するダメージ(肌荒れ・皮膚割れ)を回避し、投与時の安全性を確保するには如何にすればよいかを種々検討し、実験と試作を重ねた。そして、従来の被膜形成型製剤が被膜形成時に皮膚角質層の保湿成分を奪うことを防止できれば問題点を解決できると確信した。水分を直接添加することは製剤的特長として不可能(水分を投与前、つまり被膜形成前の被膜形成型製剤に添加すれば投与前の段階で被膜成分と水が反応し、水不溶物を形成するため)であることから、被膜形成後に水分を含有させることが必然とされ、被膜形成後の保湿目的で種々の水溶性高分子の添加する組み合わせも含めて検討した。 The present inventor instantly forms a film on the application part of the conventional film-forming preparation, protects the affected part with the formed film, and does not reduce the effect of the contained drug, and can damage the skin of the application part, which can be said to be a side effect (rough skin Various studies were conducted on how to avoid skin cracks) and ensure safety during administration, and experiments and trial production were repeated. And it was convinced that the problem could be solved if the conventional film-forming preparation could be prevented from depriving the skin stratum corneum during the film formation. It is impossible to add water directly as a pharmaceutical feature (if water is added to a film-forming preparation before administration, that is, before film formation, the film component reacts with water at the pre-administration stage to form a water-insoluble material. Therefore, it is inevitable that water is contained after the film is formed, and studies were made including combinations of various water-soluble polymers added for the purpose of moisture retention after the film was formed.
その結果、一定量の限界はあるものの水溶性高分子を添加した製剤組成で塗布後皮膚上に被膜を形成させることができた。しかしながら、被膜の強度が従来の被膜形成型製剤に比較して弱く、特に水分との接触において被膜が破れる傾向が認められた。この原因として製剤に含有された水溶性高分子が水分を吸収して膨張し、被膜強度と均一性のバランスを乱したものと推察された。
塗布した部位の保湿性は向上したものの、被膜自体に耐水性に欠点が認められ、被膜形成による患部の保護と効果に疑問が残った。そこで水溶性高分子の水分含有による保湿機能を保持し、吸水後の被膜の耐水性と被膜強度を高めるには如何にすればよいかの一点に集中して試行錯誤を重ねた。その結果、松脂、ロジン又はロジン酸の内、特にロジンを所定比率で添加することによって水溶性高分子を含有した製剤組成で形成した被膜の強度を格段に高め、且つ従来の水溶性高分子を含有しない被膜形成型製剤の塗布後の形成被膜の強度も高める結果を得た。更に、従来の形成被膜に無かった適度の滑り止め効果(表面粘着力)を有することも判明した。発明者は、この事実を基にして更に研究を重ねた結果、この発明を完成させることができた。
As a result, although there was a certain amount of limit, it was possible to form a film on the skin after application with a pharmaceutical composition to which a water-soluble polymer was added. However, the strength of the film was weaker than that of the conventional film-forming preparation, and the tendency of the film to be broken particularly in contact with moisture was recognized. It was speculated that the water-soluble polymer contained in the preparation absorbed water and expanded as a cause of this, and the balance between the film strength and the uniformity was disturbed.
Although the moisturizing property of the applied site was improved, a defect in water resistance was observed in the coating itself, and there was a doubt about the protection and effect of the affected part by the coating formation. Therefore, trial and error were repeated focusing on one point of how to maintain the moisture retaining function of the water-soluble polymer by containing water and increase the water resistance and film strength of the film after water absorption. As a result, among rosin, rosin, or rosin acid, the strength of the film formed by the formulation composition containing the water-soluble polymer is particularly increased by adding rosin in a predetermined ratio, and the conventional water-soluble polymer is As a result, the strength of the formed film after application of the film-forming preparation not contained was also increased. Furthermore, it has also been found that it has an appropriate anti-slip effect (surface adhesive force) that was not found in conventional coatings. As a result of further research based on this fact, the inventor was able to complete the present invention.
この発明の被膜形成型製剤は前記課題を解決したものであって、本発明の特徴は次のとおりのものである。
先ず、ニトロセルロースを、酢酸3−メチルブチル、又は酢酸イソブチル、又はアセトン、或いはこれらの混合物の溶解剤に溶解し、更にエチルアルコールを添加したものに所定量の水溶性高分子を加え、さらにロジンを所定比率で添加したものであるが、従来の被膜形成型製剤と同様な品質の被膜形成が期待でき、皮膚に塗布した後溶剤が揮散し、透明、或いは半透明のフィルムを塗布した部位の皮膚上に即座に形成することにより塗付部位をシールドし、薬物の経皮吸収性を高め、効果の持続性を発揮するが、特に、ロジンを配合することにより、形成被膜の耐水性が格段に向上し、短時間で形成被膜が脱落することが少なく、また、指の皮膚に割れ等の皮膚損傷や、それに伴う痛みの発症も少なく非常に安全に使用できるもので、更に、被膜表面も実際の人間の肌のように適度の粘性を有するものとなる。
勿論、従来の形成被膜と同様に、形成されたフィルムによって肌をシールドすることによって患部からの薬物の離脱を防ぎ、且つ衣服等の摩擦、引っ掻き等の物理的刺激から肌を防御する。つまり肌に防御盾に相当する膜を形成するのである。又、被膜形成製剤を肌に塗布後、皮膜形成時の有機溶剤揮散による皮膚角質層の水分揮散を抑制し、皮膚角質層の保湿成分の離脱を防ぐことによって、使用後の皮膚の保湿性を維持し、肌荒れ等の皮膚障害を予防する。塗付した部位と水分との直接の接触を防止することによって手洗い等によって塗付した薬効成分が肌から流出するのを防ぎ、更に衣服等の接触による薬効成分の喪失を防ぐことが効果の持続性を高めることにつながる。
形成されたフィルムは半ODT(半密封)であり通気性と保湿性を有するために従来の貼付製剤に特徴的な貼付部位の副作用(かぶれ、発赤、水泡等)はまったく認められていない。又、被膜形成型製剤の製剤構成は水分を全く含有しないために有効成分の安定性が極めて高く、一般的な外用製剤に特有の皮膚に対する悪影響を及ぼす危険性があると考えられる防腐剤や界面活性剤を使用する必要性は全く無い。
The film-forming preparation of the present invention has solved the above-mentioned problems, and the features of the present invention are as follows.
First, nitrocellulose is dissolved in a solubilizer of 3-methylbutyl acetate, isobutyl acetate, acetone, or a mixture thereof, and a predetermined amount of a water-soluble polymer is added to a solution added with ethyl alcohol, and rosin is further added. Although it is added at a predetermined ratio, it can be expected to form a film with the same quality as that of a conventional film-forming preparation, and after application to the skin, the solvent evaporates and the skin where the transparent or translucent film is applied Immediately forming on it shields the application site, enhances the transdermal absorbability of the drug and demonstrates the durability of the effect, but especially by adding rosin, the water resistance of the formed film is remarkably increased It can be used in a very safe manner with less formation of the coating film in a short period of time, less skin damage such as cracks in the finger skin, and less pain. Coating surface also comes to have a moderate viscosity as a real human skin.
Of course, like the conventional formed film, the skin is shielded by the formed film to prevent the drug from detaching from the affected area, and the skin is protected from physical stimulation such as friction and scratching of clothes. That is, a film corresponding to the defense shield is formed on the skin. In addition, after applying the film-forming preparation to the skin, it suppresses the moisture vaporization of the skin stratum corneum due to the organic solvent volatilization at the time of film formation, and prevents the moisturizing component of the skin stratum corneum from leaving, thereby improving the moisture retention of the skin after use. Maintain and prevent skin disorders such as rough skin. By preventing direct contact between the applied area and moisture, it prevents the medicinal ingredients applied by hand washing etc. from flowing out from the skin, and also prevents the loss of medicinal ingredients due to contact with clothes etc. It leads to improving sex.
Since the formed film is semi-ODT (semi-sealed) and has air permeability and moisture retention, no side effects (rash, redness, blistering, etc.) at the site of application characteristic of conventional patch preparations are observed. In addition, since the formulation of the film-forming preparation does not contain any moisture, the stability of the active ingredient is extremely high, and preservatives and interfaces that are considered to have a risk of adversely affecting the skin, which is typical of general external preparations. There is no need to use an activator.
上記の課題を解決するために、すなわち、請求項1の発明は、ニトロセルロースを、酢酸3−メチルブチル、又は酢酸イソブチル又はアセトン、或いは、これらの混合物の溶解剤に溶解し、これにエチルアルコールを添加したものに、柔軟性を有するが固化しない範囲で水分保持機能を得るために水溶性高分子を加え、更に被膜の耐水性を強化するとともに水溶性高分子ヒドロキシプロピルセルロース(0.5から10w/w%)、カルボキシビニールポリマー、ポリビニールアルコール等の水溶性高分子を含有させることを可能するためにロジンを0.1から10w/w%を添加して、皮膚に塗布した後溶剤が揮散し、塗布部位の皮膚上に透明或いは半透明のフィルムを形成することにより患部を密封し、半ODT効果(半密封効果)により含有成分の経皮吸収性を高め揮散薬物の揮散性をコントロール(抑制)し、含有薬物を徐放化することによって効果の持続性を改善し、更に塗付部を皮膜で保護したことを特徴とする被膜形成型製剤である。
請求項2の発明は、前記溶解剤の中にフィルムの摩擦係数や強度、柔軟性を調整するためにアセチル化ヒアルロン酸、ミツロウ、カルナバロウ、ラノリン、シリコーンから選択される1種類以上を添加したことを特徴とする請求項1に記載の被膜形成型製剤である。
請求項3の発明は、前記溶解剤の中に膜形成時の膜の強度・柔軟性とODT効果を高めるようにするためにシソオイル、ごま油、エゴマ油、オリーブ油、馬油、ヒノキオイル、ひまし油の天然油、合成のシリコーン油から選択される一種以上を含有することを特徴とする請求項1に記載の被膜形成型製剤である。
請求項4の発明は、前記水溶性高分子は、ヒドロキシプロピルセルロース、カルボキシビニールポリマー、ポリビニールアルコールから選択される一種以上であることを特徴する請求項1に記載の被膜形成型製剤である。
In order to solve the above-mentioned problems, that is, the invention of
A second aspect of the present invention, the friction coefficient and strength of the film in said dissolution agent, acetylated hyaluronic acid to adjust the flexibility, beeswax, carnauba wax, lanolin, and added pressure to the one or more selected from a silicone The film-forming preparation according to
According to the invention of
The invention according to
以上のように、本発明の被膜形成型製剤によれば、ニトロセルロースを、酢酸3−メチルブチル、又は酢酸イソブチル、又はアセトン、或いはこれらの混合物の溶解剤に溶解し、更にエチルアルコールを添加した基剤に、所望の薬効成分や忌避成分を加えて種々の保湿成分を添加したものにロジンを加えたものであり、皮膚に塗布した後有機溶剤が揮散し、皮膚角質層の水分を含む保湿成分の離脱を極力抑えて皮膚の保湿機能を維持しつつ透明、或いは半透明の被膜を皮膚上に形成する。そのことにより、塗付部位を半密封・保護し、含有成分の経皮吸収性を高めることによって、効果とその持続性を高め、衣服・掻くことによる物理的刺激から肌を守り、更に貼付剤に多く見られる皮膚刺激による発赤・浮腫形成といったかぶれを防止する。最悪の場合に外用製剤に多く認められる皮膚刺激による痒みの発生で患部を掻き壊しによる炎症の発生・増悪も防止することができる。
更に、形成被膜時に揮散する有機溶剤が殺菌効果を有するために塗布患部の殺菌を同時に実施することが可能となる。創傷部位や感染部位の皮膚殺菌には余分な殺菌剤も不用であり、最適な投与形体である。
As described above, according to the film-forming preparation of the present invention, nitrocellulose is dissolved in a solubilizer of 3-methylbutyl acetate, isobutyl acetate, acetone, or a mixture thereof, and further added with ethyl alcohol. The rosin is added to the preparation with various moisturizing ingredients added with the desired medicinal ingredients and repellent ingredients. After applying to the skin, the organic solvent is volatilized, and the moisturizing ingredients contain moisture from the skin stratum corneum A transparent or translucent film is formed on the skin while keeping the skin moisturizing function while suppressing the separation of the skin as much as possible. As a result, the application site is semi-sealed and protected, and the percutaneous absorbability of the ingredients is increased, thereby improving the effect and its durability, protecting the skin from physical irritation caused by clothes and scratching, and further patching Prevents rashes such as redness and edema formation caused by skin irritation, which are often seen in skin. Occurrence and exacerbation of inflammation caused by scratching the affected area can be prevented by the occurrence of itching caused by skin irritation, which is often observed in external preparations in the worst case.
Furthermore, since the organic solvent that volatilizes at the time of the formed film has a sterilizing effect, it becomes possible to simultaneously sterilize the affected area. An extra bactericidal agent is not required for skin sterilization of wound sites and infected sites, and is an optimal dosage form.
基剤単独でも膏体を薄く塗布した皮膚上に皮膜を形成することによって皮膚の保湿性を維持しつつ皮膚自体をガードし、衣服や草木等による擦過といった物理的刺激から皮膚を守る作用を発揮する。つまり形成被膜自体が強靭な第二の人工角質層にもなり得る。すなわち、被膜形成型製剤にロジンを添加することによって、皮膚上に形成された被膜の前記課題を解決するために働き、更に、蚊や虫に刺されることから防護することも可能である。
また、水溶性高分子を添加することによって保湿成分に離脱を抑え、使用時の水溶性高分子の水分保持機能によって皮膚障害を予防でき、さらに、連続使用による皮膚障害を抑えることができる。
Even with the base alone, it forms a film on the skin where the plaster is thinly applied to protect the skin itself while maintaining the moisture retention of the skin, and protects the skin from physical irritation such as rubbing with clothes and plants. To do. That is, the formed coating itself can be a tough second artificial stratum corneum. That is, by adding rosin to the film-forming preparation, it works to solve the above-mentioned problems of the film formed on the skin, and further it can be protected from being bitten by mosquitoes and insects.
Further, by adding a water-soluble polymer, it is possible to suppress detachment to the moisturizing component, prevent skin damage by the water retention function of the water-soluble polymer at the time of use, and further suppress skin damage due to continuous use.
本発明は、先行技術の被膜形成型製剤に、ロジンを所定比率で添加したものであり、ロジン単独でも配合でも前記と同様な品質の被膜形成が期待でき、皮膚に塗布した後溶剤が揮散し、透明、或いは半透明のフィルムを塗布した部位の皮膚上に即座に形成することにより塗付部位をシールドし、薬物の経皮吸収性を高め、効果の持続性を発揮させることを実現したものである。
なお、ロジンの単独使用の場合に比べて作用・効果証多少劣るが、ロジンに変えてロジンと同等のロジン酸や松脂、あるいはこれらを混合したものを用いてもよい。
In the present invention, a rosin is added to a prior art film-forming preparation at a predetermined ratio, and the formation of a film with the same quality as described above can be expected with rosin alone or in combination, and the solvent is volatilized after being applied to the skin. Realizes that the application site is shielded by instantly forming on the skin where the transparent or translucent film is applied, and the percutaneous absorption of the drug is enhanced, and the effect is sustained. It is.
Although the proof of action and effect is somewhat inferior to the case of using rosin alone, rosin acid equivalent to rosin, rosin, or a mixture thereof may be used instead of rosin.
本発明の被膜形成型製剤の実施例について、以下に説明する。
本発明の被膜形成型製剤の好適な実施例を説明するが、先ず、この実施例1の配合比は次の[表1]に示すものである。
[実施例1]
[表1]
[組成比]
ニトロセルロース・・・・・・・・・・7.0w/w%
ヒドロキシプロピルセルロース・・・・1.0w/w%
エチルアルコール・・・・・・・・・70.0w/w%
酢酸3−メチルブチル・・・・・・・・5.0w/w%
アセトン・・・・・・・・・・・・・10.0w/w%
ロジン・・・・・・・・・・・・・・・3.0w/w%
シリコーン・・・・・・・・・・・・・2.0w/w%
ゴマ油・・・・・・・・・・・・・・・1.0w/w%
ひまし油・・・・・・・・・・・・・・1.0w/w%
合計:100.0w/w%
Examples of the film-forming preparation of the present invention will be described below.
Preferred examples of the film-forming preparation of the present invention will be described. First, the blending ratio of Example 1 is shown in the following [Table 1].
[Example 1]
[Table 1]
[Composition ratio]
Nitrocellulose: 7.0 w / w%
Hydroxypropylcellulose ... 1.0w / w%
Ethyl alcohol ... 70.0 w / w%
3-methylbutyl acetate: 5.0 w / w%
Acetone: 10.0 w / w%
Rosin …… 3.0w / w%
Silicone: 2.0w / w%
Sesame oil ... 1.0w / w%
Castor oil ... 1.0w / w%
Total: 100.0 w / w%
[調製方法]
上記の組成比になるように本実施例の被膜形成型製剤は、次のような手順で調製した。
先ず、ニトロセルロースとヒドロキシプロピルセルロースを酢酸3−メチルブチルに溶解させたのち、更にアセトンを添加して常温にて良く攪拌した。 次にこの溶解液にエチルアルコールを加えて良く攪拌したのち、シリコーン、ゴマ油、ひまし油、最後にロジンと順次攪拌下に少量ずつ添加し、3時間撹拌・練合した後、密封した状態で12時間室温放置して製造した。
ここで、ロジンのw/w%(重量%)は、0.1%から10w/w%が適量であるが、後述するように、0.1w/w%以下では効果が確認できず、10w/w%以上となると粘性が高くなり、被膜が形成し難くなり、皮膚のかぶれが生ずる等の不都合が生じたので、1〜5w/w%がより好ましい。また、被膜形成にはニトロセルロースが5〜10w/w%が適量であるが、この値によって最良効果を得るロジンのw/w%も多少変化するが、いずれにしても0.1%から10w/w%、より好ましくは1〜5w/w%の範囲で初期の作用効果が得られる。ここで、ニトロセルロースが5〜10w/w%の範囲でそのw/w%が多くなれば、ロジンのw/w%は0.1%から10w/w%の範囲でそのw/w%少なくなり、ニトロセルロースが5〜10w/w%の範囲でそのw/w%少なくなれば、ロジンのw/w%は0.1%から10w/w%の範囲でそのw/w%が多くなるが、その変動は僅かである。
なお、本実施例で使用したロジンは、松の木などのオレオレジンから抽出し精製した天然の硬化樹脂で酸価が150〜177で、灰分が0.1%以下の日本薬局方に合致したものである。また、ロジンに変えてロジンと同等のロジン酸や松脂、あるいはこれらを混合したものを用いてもよいが、ロジンの単独使用の場合に比べて作用・効果は多少劣ることが、実験の結果判明した。
[Preparation method]
The film-forming preparation of this example was prepared by the following procedure so as to achieve the above composition ratio.
First, after nitrocellulose and hydroxypropylcellulose were dissolved in 3-methylbutyl acetate, acetone was further added and stirred well at room temperature. Next, ethyl alcohol was added to this solution and stirred well, then silicone, sesame oil, castor oil, and finally rosin were added in small portions under sequential stirring. After stirring and kneading for 3 hours, the solution was sealed for 12 hours. Manufactured by standing at room temperature.
Here, the appropriate amount of rosin w / w% (% by weight) is 0.1% to 10w / w%, but as will be described later, the effect cannot be confirmed at 0.1w / w% or less. When it exceeds w%, the viscosity becomes high, it becomes difficult to form a film, and skin irritation occurs. Therefore, 1 to 5 w / w% is more preferable. In addition, the appropriate amount of nitrocellulose is 5 to 10 w / w% for film formation, but the w / w% of rosin that obtains the best effect varies somewhat depending on this value, but in any case 0.1% to 10 w The initial effect can be obtained in the range of 1 / w%, more preferably 1-5% w / w%. Here, if the w / w% of nitrocellulose increases in the range of 5 to 10 w / w%, the w / w% of rosin decreases by 0.1% to 10 w / w% in the range of 0.1 to 10 w / w%. If the w / w% of nitrocellulose decreases in the range of 5-10 w / w%, the w / w% of rosin increases in the range of 0.1% to 10 w / w%. However, the fluctuation is slight.
The rosin used in this example is a natural cured resin extracted from oleoresin such as pine tree and purified, and has an acid value of 150 to 177 and accord with the Japanese Pharmacopoeia with an ash content of 0.1% or less. is there. In addition to rosin, rosin acid equivalent to rosin, rosin, or a mixture of these may be used, but the results show that the effects and effects are somewhat inferior compared to rosin alone. did.
なお、実施例1では、フィルム状の被膜形成素材となるニトロセルロースを7.0w/w%としたが、上述したように5.0〜10.0w/wが適量である。同様に、フィルム形成素材としてエチルアルコールは60.0〜80.0w/w%、好ましくは70.0w/w%、酢酸3−メチルブチルは3.0〜8.0w/w%、好ましくは5.0w/w%、アセトンは8.0〜12.0w/w%、好ましくは10.0w/w%を溶解させればよい。
また、保湿等のための水溶性高分子であるヒドロキシプロピルセルロースは0.5から3.0w/w%で、0.5w/w%以下だと使用の際の柔軟性が欠け、3.00w/w%以上だと固化してしまい、好ましくは、1.0から2.0w/w%で、更に好ましくは1.0w/w%である。さらに、摩擦係数や強度、柔軟性を調整するシリコーンは1.0〜3.0w/w%、好ましくは2.0w/w%、膜形成時の膜の強度・柔軟性とODT効果を高めるようにするためにゴマ油は0.5〜2.0w/w%、好ましくは1.0w/w%、同様にひまし油も0.5〜2.0w/w%、好ましくは1.0w/w%を順次攪拌下に少量ずつ添加すればよい。
In Example 1, 7.0% w / w of nitrocellulose as a film-form film forming material was used, but as described above, an appropriate amount is 5.0 to 10.0w / w. Similarly, as a film forming material, ethyl alcohol is 60.0 to 80.0 w / w%, preferably 70.0 w / w%, and 3-methylbutyl acetate is 3.0 to 8.0 w / w%, preferably 5. 0 w / w%, acetone may be dissolved 8.0 to 12.0 w / w%, preferably 10.0 w / w%.
Hydroxypropyl cellulose, which is a water-soluble polymer for moisturizing, etc., is 0.5 to 3.0 w / w%, and if it is 0.5 w / w% or less, it lacks flexibility when used. If it is / w% or more, it solidifies, preferably 1.0 to 2.0 w / w%, more preferably 1.0 w / w%. Furthermore, the silicone for adjusting the coefficient of friction, strength, and flexibility is 1.0 to 3.0 w / w%, preferably 2.0 w / w%, so as to increase the strength and flexibility of the film and the ODT effect during film formation. In order to make sesame oil, 0.5 to 2.0 w / w%, preferably 1.0 w / w%, and similarly castor oil 0.5 to 2.0 w / w%, preferably 1.0 w / w%. What is necessary is just to add little by little under sequential stirring.
本発明の実施例1に対比する比較例1の配合比を[表2]に示す。
[比較例1]
[表2]
[組成比]
ニトロセルロース・・・・・・・・・・7.0w/w%
ヒドロキシプロピルセルロース・・・・1.0w/w%
エチルアルコール・・・・・・・・・73.0w/w%
酢酸3−メチルブチル・・・・・・・・5.0w/w%
アセトン・・・・・・・・・・・・・10.0w/w%
シリコーン・・・・・・・・・・・・・2.0w/w%
ゴマ油・・・・・・・・・・・・・・・1.0w/w%
ひまし油・・・・・・・・・・・・・・1.0w/w%
合計:100.0w/w%
The mixing ratio of Comparative Example 1 as compared with Example 1 of the present invention is shown in [Table 2].
[Comparative Example 1]
[Table 2]
[Composition ratio]
Nitrocellulose: 7.0 w / w%
Hydroxypropylcellulose ... 1.0w / w%
Ethyl alcohol ... 73.0w / w%
3-methylbutyl acetate: 5.0 w / w%
Acetone: 10.0 w / w%
Silicone: 2.0w / w%
Sesame oil ... 1.0w / w%
Castor oil ... 1.0w / w%
Total: 100.0 w / w%
[調製方法]
上記の組成比になるように比較例1の被膜形成型製剤は実施例1と同様に、次のような手順で調製した。
ニトロセルロースとヒドロキシプロピルセルロースを酢酸3−メチルブチルに溶解させたのち、更にアセトンを添加して常温にて良く攪拌した。次にこの溶解液にエチルアルコールを加えてよく攪拌したのち、シリコーン、ゴマ油、ひまし油を順次攪拌下に少量ずつ添加し、3時間攪拌・練合した後、密封した状態で12時間室温放置して製造した。
[Preparation method]
The film-forming preparation of Comparative Example 1 was prepared in the following procedure in the same manner as in Example 1 so that the composition ratio was as described above.
Nitrocellulose and hydroxypropylcellulose were dissolved in 3-methylbutyl acetate, and then acetone was further added and stirred well at room temperature. Next, after adding ethyl alcohol to this solution and stirring well, silicone, sesame oil, and castor oil are added in small portions under stirring, and stirred and kneaded for 3 hours, and then left at room temperature for 12 hours in a sealed state. Manufactured.
本発明の実施例1に対比する比較例2の配合比を[表3]に示す。
[比較例2]
[表3]
[組成比]
ニトロセルロース・・・・・・・・・・7.0w/w%
エチルアルコール・・・・・・・・・74.0w/w%
酢酸3−メチルブチル・・・・・・・・5.0w/w%
アセトン・・・・・・・・・・・・・10.0w/w%
シリコーン・・・・・・・・・・・・・2.0w/w%
ゴマ油・・・・・・・・・・・・・・・1.0w/w%
ひまし油・・・・・・・・・・・・・・1.0w/w%
合計:100.0w/w%
The blending ratio of Comparative Example 2 as compared with Example 1 of the present invention is shown in [Table 3].
[Comparative Example 2]
[Table 3]
[Composition ratio]
Nitrocellulose: 7.0 w / w%
Ethyl alcohol ... 74.0 w / w%
3-methylbutyl acetate: 5.0 w / w%
Acetone: 10.0 w / w%
Silicone: 2.0w / w%
Sesame oil ... 1.0w / w%
Castor oil ... 1.0w / w%
Total: 100.0 w / w%
[調製方法]
上記の組成比になるように比較例2の被膜形成型製剤も、比較例1と同様に、次のような手順で調製した。ニトロセルロースを酢酸3−メチルブチルに溶解させたのち、更にアセトンを添加して常温にて良く攪拌した。次にこの溶解液にエチルアルコールを加えて良く攪拌したのち、シリコーン、ゴマ油、ひまし油を順次攪拌下に少量ずつ添加し、3時間攪拌・練合した後、密封した状態で12時間室温放置して製造した。
[Preparation method]
Similarly to Comparative Example 1, the film-forming preparation of Comparative Example 2 was also prepared by the following procedure so as to achieve the above composition ratio. After nitrocellulose was dissolved in 3-methylbutyl acetate, acetone was further added and stirred well at room temperature. Next, after adding ethyl alcohol to this solution and stirring well, silicone, sesame oil, and castor oil were added in small portions under sequential stirring, followed by stirring and kneading for 3 hours, and then allowed to stand at room temperature for 12 hours in a sealed state. Manufactured.
[耐水性試験]
上記の組成、及び調整法で製造した実施例の被膜形成型製剤の形成被膜の耐水性を以下の条件で検証した。
(1)被検体:実施例1(上記の実施例製剤:以下「実施例品」という。)
対照製品:比較例1、比較例2
(2)試験方法:
スライドグラス(厚さ:0.9〜1.2mm・面積:76×26mm)上に各々スポイトを用いて採取した被検体を1mlずつ滴下し、綿棒を用いてスライドグラス上に一定の厚さに均一に塗布した。5分経過後、スライドグラスの非塗布部(裏面)よりドライヤーを用いて10秒間熱風乾燥を施した。次に乾燥したスライドグラスを約30℃に加温した精製水で満たした一定の整列容器に1枚ずつ浸した。その後7日目まで毎日浸漬したスライドグラスを取り出し、スライドグラス上に形成された被膜の状態を観察し、下記の評価基準に従って被膜の剥離度を評価した。更に、温水に界面活性剤(Tween80)を1w/w%添加し、良く攪拌したのち上記と同様な条件で浸漬試験を実施し、下記の評価基準に従って評価した。
評価基準:正常(殆ど破損無し): 5点
僅かに破損(10%以下):4点
一部破損(10〜20%):3点
やや破損(20〜50%):2点
かなり破損(50%以上):1点
殆ど破損(90%以上): 0点
[Water resistance test]
The water resistance of the formed film of the film-forming preparation of the Example produced by the above composition and adjustment method was verified under the following conditions.
(1) Subject: Example 1 (the above-mentioned Example preparation: hereinafter referred to as “Example product”)
Control product: Comparative Example 1 and Comparative Example 2
(2) Test method:
1 ml of each sample collected using a dropper is dropped on a slide glass (thickness: 0.9 to 1.2 mm, area: 76 × 26 mm), and a constant thickness is applied onto the slide glass using a cotton swab. It was applied evenly. After 5 minutes, hot air drying was performed for 10 seconds using a drier from the non-coated part (back surface) of the slide glass. Next, the dried slide glass was immersed one by one in a fixed alignment container filled with purified water heated to about 30 ° C. Thereafter, the slide glass soaked every day until the seventh day was taken out, the state of the film formed on the slide glass was observed, and the degree of peeling of the film was evaluated according to the following evaluation criteria. Furthermore, after adding 1 w / w% of a surfactant (Tween 80) to warm water and stirring well, an immersion test was performed under the same conditions as described above, and evaluation was performed according to the following evaluation criteria.
Evaluation criteria: Normal (almost no damage): 5 points
Slightly damaged (10% or less): 4 points
Partially damaged (10-20%): 3 points
Slightly damaged (20-50%): 2 points
Very damaged (50% or more): 1 point
Almost damaged (90% or more): 0 points
(3)試験結果
前記形成被膜の耐水性の試験結果を[表4]に示す。
この[表4]に示すように、温水に浸漬した場合は、本発明の実施例1の実施例品では7日間の試験期間中に被膜の脱落は全く観察されなかった。これに対して比較例1では1日目から被膜の軽度の脱落傾向が認められ、2日目には完全に被膜が脱落する例が出現し、3日目には総ての例で被膜が完全に脱落した。比較例2では2日目までは被膜に変化は無かったが3〜4日から軽度の脱落傾向が5日目まで認められ、6日には総ての例で被膜が完全に脱落したのを確認した。
温水に界面活性剤を添加した溶液に被検体を浸漬した試験では、実施例品では7日間の試験期間中に被膜が脱落・破損する例は皆無であった。これに対して比較例1では試験1日目で被膜の一部の脱落が全例に確認され、2日目には総ての被膜が脱落した。比較例2では試験1日目は被膜に全く脱落は無かったが2日目の一部に脱落が認められ、その傾向は経日的に強くなり試験5日目には総ての被膜が完全に脱落した。
以上の結果から実施例品は温水及び界面活性剤を添加した温水に浸漬した状態でも7日間の試験期間中に形成被膜が脱落することは全く確認されなかったこと、更に皮膚の保水性改善を目的として処方した比較例1と従来の被膜形成型製剤処方である比較例2に比較しても飛躍的に被膜の特性が改善されたことが実証された。
(3) Test results The water resistance test results of the formed coating are shown in [Table 4].
As shown in [Table 4], when immersed in warm water, no dropout of the film was observed during the test period of 7 days in the example product of Example 1 of the present invention. On the other hand, in Comparative Example 1, there was a slight tendency of the film to fall off from the first day, and on the second day, there was an example where the film was completely dropped. It dropped out completely. In Comparative Example 2, there was no change in the coating until the second day, but a slight tendency to fall off was observed from the 3rd to 4th days until the fifth day. confirmed.
In the test in which the specimen was immersed in a solution in which a surfactant was added to warm water, there were no examples in which the coating film dropped or damaged during the test period of 7 days in the example products. On the other hand, in Comparative Example 1, all of the coatings were removed on the first day of the test, and all of the coatings were removed on the second day. In Comparative Example 2, the film did not drop off at all on the first day of the test, but a part of the film on the second day was observed to drop off, and the tendency became stronger over time. Dropped out.
From the above results, it was confirmed that the formed product did not fall off during the test period of 7 days even in the case of being immersed in warm water and warm water to which a surfactant was added, and further improving the water retention of the skin. It was demonstrated that the characteristics of the coating were dramatically improved even when compared with Comparative Example 1 formulated as an object and Comparative Example 2 as a conventional film-forming preparation formulation.
[皮膚損傷試験]
上記の組成、及び調製方法で製造した実施例1の皮膚角質層の水分ロスに伴う皮膚損傷に対する効果を以下の条件で検証した。
(1)被検体:実施例1(上記の実施例1の製剤:以下「実施例品」という。)
対照製品:比較例1、比較例2
(2)被験者:22歳〜35歳女性
(3)試験方法:
被検体3種類を口径2.5cm、容量30mlの3個プラスチック性容器に各30ml入れ、これをA(実施例品)、B(比較例1)、C(比較例2)とした。次に被験者の右手人差し指をAに、中指をBに、薬指をCにそれぞれ指の第一関節部まで浸漬し、数秒後に容器から各指を抜き、約5分間手を使わない状態で自然乾燥させた。この処置を毎朝10時に実施し、24時間後に指の先端部位の皮膚の損傷度を下記の判定基準に従って判定した。この操作は7日間連続して実施した。
尚、試験期間中被験者は拘束条件を付けずに通常の生活行動に影響の無い状態で生活してもらった。
判定基準:皮膚割れ無し・痛み無し :0点
軽度の皮膚割れ・痛み無し :1点
軽度の皮膚割れ・痛み有り :2点
中等度の皮膚割れ・痛み有り:3点
強度の皮膚割れ・痛み有り :4点
[Skin damage test]
The effect on skin damage due to moisture loss of the skin stratum corneum of Example 1 produced by the above composition and preparation method was verified under the following conditions.
(1) Subject: Example 1 (Formulation of Example 1 above: hereinafter referred to as “Example product”)
Control product: Comparative Example 1 and Comparative Example 2
(2) Subject: Female aged 22-35 (3) Test method:
Three kinds of subjects were placed in three plastic containers each having a diameter of 2.5 cm and a capacity of 30 ml, and these were designated as A (Example product), B (Comparative example 1), and C (Comparative example 2). Next, immerse the subject's right index finger to A, middle finger to B, and ring finger to C to the first joint of the finger. After a few seconds, remove each finger from the container and let it dry for about 5 minutes without using your hand. I let you. This treatment was performed every morning at 10:00, and after 24 hours, the degree of skin damage at the tip of the finger was determined according to the following criteria. This operation was carried out for 7 consecutive days.
During the test period, the subjects were allowed to live without any restrictions on their normal living behavior.
Criteria: No skin cracking / pain: 0 points
No minor skin cracks / pain: 1 point
Mild skin cracks / pain: 2 points
Moderate skin crack / pain: 3 points
Strong skin crack / pain: 4 points
(4)試験結果:
皮膚損傷に対する効果の試験結果を[表5]に示す。[表5]に示すように、本発明の実施例1の実施例品は7日間の連続して人差し指に浸漬を繰り返したが、指の皮膚に割れは全く確認されず、従って皮膚割れに伴う痛みの訴えも皆無であった。これに対して比較例1は試験開始3日目までは中指の皮膚に特に変化は認められなかったが、4日目に軽度の皮膚割れと痛みを発症する例が2人に認められた。その後軽度ながら経日的に症状の程度と例数に増加傾向が認められ、試験最終日には全例が軽度以上の皮膚割れと痛み有り以上の症状を呈した。比較例2では試験開始1日目から薬指に痛みを伴わない軽度の皮膚割れが2例に認められ、2日目以降、比較例1の倍以上の速さと程度で症状の悪化が進行し3日目からは総ての例で痛みが発症し、試験最終日まで痛みの症状は持続し、且つ皮膚割れの程度も殆ど強度となった。
以上の結果から比較例1及び2に比較して実施例品は7日間連続使用しても指の先端皮膚に全く影響を与えなかったことから、非常に安全に使用できる被膜形成型製剤であ
ると考えられた。
(4) Test results:
The test results of the effect on skin damage are shown in [Table 5]. As shown in [Table 5], the product of Example 1 of the present invention was repeatedly immersed in the index finger for 7 days continuously, but no cracks were confirmed in the finger skin, and therefore accompanied by skin cracks. There was no complaint of pain. In contrast, Comparative Example 1 showed no particular change in the skin of the middle finger until the third day after the start of the test, but two cases of mild skin cracking and pain were observed on the fourth day. After that, the degree of symptom and the number of cases gradually increased although they were mild. On the last day of the study, all cases showed mild skin cracking and painful symptoms. In Comparative Example 2, mild skin cracking without pain in the ring finger was observed in 2 cases from the first day of the test, and the worsening of the symptoms progressed at a rate twice as fast as Comparative Example 1 from the second day. From the first day, pain developed in all cases, the symptoms of pain persisted until the last day of the test, and the degree of skin cracking became almost intense.
From the above results, compared to Comparative Examples 1 and 2, the Example product did not affect the fingertip skin at all even after 7 days of continuous use, so it is a film-forming preparation that can be used very safely. It was considered.
[滑り止め試験]
上記の組成及び調製方法で製造した実施例1の被膜形成後の被膜自体の滑り止め効果をコロガリタック試験法を利用して以下の条件で検証した。
(1)被検体:実施例1(上記実施例1の製剤:以下「実施例品」という)
対照製品:比較例1、比較例2
(2)被検体の調製:実施例品、比較例1及び2をそれぞれガラス板上に0.1g/ 1cm×1cm)の割合で綿棒を用いて均一に塗布し、3分間の自然乾燥後、ドライヤーを用いてガラス裏面より30秒間乾燥させた後、精製水を満たした浸漬槽に浸漬した。3時間後に浸漬槽から取り出し、ピンセットを用いてガラス板上に形成された被膜をピンセットを用いて丁寧に剥離し、水分除去したものを各被検体とした。
(3)試験方法:コロガリタック試験法(医薬品製造指針)準拠して実施した。傾斜角30度の試験器の斜面端に形成被膜(2cm×5cm)をセットし、試験器の上端からスチールボール(No.1:直径3.2mm、重量0.13g、No.2:直径4.8mm、重量0.45g)を転がし、スチールボールが被検体上で停止した位置を斜面末端から計測してその転がり距離を測定した。被検体上のスチールボールの転がりが短いほど粘着力が良いといったことを指標判断とした。
[Anti-slip test]
The anti-slip effect of the coating itself after forming the coating of Example 1 produced by the above composition and preparation method was verified under the following conditions using the Korogari Tack test method.
(1) Subject: Example 1 (Formulation of Example 1 above: hereinafter referred to as “Example product”)
Control product: Comparative Example 1 and Comparative Example 2
(2) Preparation of specimen: Example product and Comparative Examples 1 and 2 were each uniformly applied on a glass plate at a rate of 0.1 g / 1 cm × 1 cm) using a cotton swab, and after natural drying for 3 minutes, After drying for 30 seconds from the back surface of the glass using a drier, it was immersed in an immersion tank filled with purified water. After 3 hours, the specimen was taken out from the immersion tank, and the film formed on the glass plate using tweezers was carefully peeled off using tweezers, and the water was removed to make each specimen.
(3) Test method: The test was carried out in accordance with the Kologaritak test method (pharmaceutical production guideline). A coating film (2cm x 5cm) is set on the slope end of the tester with an inclination angle of 30 degrees, and steel balls (No.1: diameter 3.2mm, weight 0.13g, No.2: diameter 4.8mm, from the upper end of the tester) The rolling distance was measured by measuring the position where the steel ball stopped on the specimen from the end of the slope. The index judgment was that the shorter the rolling of the steel ball on the subject, the better the adhesive strength.
(4)試験結果:
被膜形成後の被膜自体の滑り止め効果の試験結果を[表6]に示す。[表6]に示すように、比較的軽いスチールボールNo.1を使用した場合は、本発明の実施例1の実施例品では5回の試技で総てのボールが形成被膜上0.8〜1.5cmで停止し、その転がり距離は平均で1.14cmであった。また、比較的重いスチールボールNo.2を使用した場合は、5回の試技で総てのボールが形成被膜上2.0〜2.8cmで停止し、その転がり距離は平均で2.58cmであった。
また、これに対して対照である比較例1及び2ではNo.1及び2の何れのスチールボールも5回の試技で形成被膜上で停止した例は全く無かった。
以上の結果から、実施例品は従来の被膜形成型製剤や保湿機能改善被膜に比較して、形成被膜は実際の人間の肌と同様に適度の粘着性やざらつきを有することが明確になった。
(4) Test results:
Table 6 shows the test results of the anti-slip effect of the coating itself after the coating is formed. As shown in [Table 6], when a relatively light steel ball No. 1 was used, in the example product of Example 1 of the present invention, all balls were 0.8 on the formed coating after 5 trials. Stopping at ˜1.5 cm, the rolling distance averaged 1.14 cm. When relatively heavy steel ball No. 2 was used, all the balls stopped at 2.0 to 2.8 cm on the formed film after 5 trials, and the rolling distance averaged 2.58 cm. there were.
On the other hand, in Comparative Examples 1 and 2, which is a control, none of the steel balls of No. 1 and 2 stopped on the formed film in 5 trials.
From the above results, it was clarified that the example products have moderate tackiness and roughness as in the case of actual human skin, compared to the conventional film-forming preparations and the moisture-retaining function-improving coatings. .
以上のように、本発明の実施例の被膜形成型製剤の特徴は、ニトロセルロースを、酢酸3−メチルブチル、又は酢酸イソブチル、又はアセトン、或いはこれらの混合物の溶解剤に溶解し、更にエチルアルコールを添加した基剤に忌避成分を加えて種々の保湿成分を添加したものにロジンを加えたものである。この構成により、特に、ロジンを配合することで、形成被膜の耐水性が格段に向上し、短時間で形成被膜が脱落することが少なく、また、指の皮膚に割れ等の皮膚損傷や、それに伴う痛みの発症も少なく非常に安全に使用できるもので、更に、被膜表面も実際の人間の肌と同様に適度の粘着性やざらつきを有するようになる。このように、水溶性高分子を添加することができるので保湿成分が離脱を抑え、使用時の水溶性高分子の水分保持機能によって皮膚障害を予防でき、さらに、連続使用による皮膚障害を抑えることもできる。
また、従来の被膜形成型製剤と同様に、皮膚に塗布した後有機溶剤が揮散し、皮膚角質層の水分を含む保湿成分の離脱を極力抑えて皮膚の保湿機能を維持しつつ透明、或いは半透明の被膜を皮膚上に形成する。そのことにより、塗付部位を半密封・保護し、含有成分の経皮吸収性を高めることによって、効果とその持続性を高め、衣服・掻くことによる物理的刺激から肌を守り、更に貼付剤に多く見られる皮膚刺激による発赤・浮腫形成といったかぶれを防止する。最悪の場合に外用製剤に多く認められる皮膚刺激による痒みの発生で患部を掻き壊しによる炎症の発生・増悪が生じるが、これを防止することができる。更に、形成被膜時に揮散する有機溶剤が殺菌効果を有するために塗布患部の殺菌を同時に実施することが可能となる。創傷部位や感染部位の皮膚殺菌には余分な殺菌剤も不用であり、最適の投与形体である。
更に、病的皮膚、例えば水虫等の場合は、基材に含有するアルコールによる患部の殺菌と、アルコール揮発に伴う病的皮膚組織からの浸出液中の水分、及び、病的皮膚組織自体から水分を奪うことによって、水虫菌の増殖を抑制し、含有抗菌剤の高めることができる。更に、患部の菌を被覆で封じ込めることによって、第三者への感染を予防できる。
As described above, the characteristics of the film-forming preparations of the examples of the present invention are that nitrocellulose is dissolved in a solubilizer of 3-methylbutyl acetate, isobutyl acetate, acetone, or a mixture thereof, and further ethyl alcohol is dissolved. A rosin is added to the base added with various repellent ingredients and various moisturizing ingredients. With this configuration, in particular, by adding rosin, the water resistance of the formed film is remarkably improved, and the formed film is less likely to fall off in a short period of time. There is little onset of pain and it can be used very safely, and the surface of the coating also has moderate stickiness and roughness like real human skin. In this way, water-soluble polymers can be added, so that moisturizing ingredients can be prevented from detaching, and the water-holding function of the water-soluble polymer during use can prevent skin damage, and further suppress skin damage due to continuous use. You can also.
In addition, as with conventional film-forming preparations, the organic solvent is volatilized after application to the skin, and it is transparent while maintaining the skin moisturizing function by minimizing the detachment of the moisturizing ingredients including moisture in the skin stratum corneum. A transparent film is formed on the skin. As a result, the application site is semi-sealed and protected, and the percutaneous absorbability of the ingredients is increased, thereby improving the effect and its durability, protecting the skin from physical irritation caused by clothes and scratching, and further patching Prevents rashes such as redness and edema formation caused by skin irritation, which are often seen in skin. In the worst case, the occurrence of itch caused by skin irritation, which is often observed in external preparations, causes the occurrence or exacerbation of inflammation due to the scratching of the affected area, which can be prevented. Furthermore, since the organic solvent that volatilizes at the time of the formed film has a sterilizing effect, it becomes possible to simultaneously sterilize the affected area. An extra bactericidal agent is not required for skin sterilization of wound sites and infected sites, and is an optimal dosage form.
Furthermore, in the case of pathological skin, such as athlete's foot, the sterilization of the affected area with alcohol contained in the base material, moisture in the exudate from the pathological skin tissue accompanying alcohol volatilization, and water from the pathological skin tissue itself By depriving it, it is possible to suppress the growth of athlete's foot bacteria and increase the content of the antibacterial agent. Furthermore, infection to a third party can be prevented by enclosing the affected bacteria with a coating.
言い換えれば、基材に有薬物を含有させた場合は、患部への経皮吸収性を改善し、局所の治療効果を高め、更に患部を皮膜で保護することによって外部からの物理的、化学的刺激や細菌感染を防ぐもので、皮膚に塗布した後溶剤が揮散し、透明、或いは半透明のフィルムを塗布した患部の皮膚上に形成することにより患部を密封し、薬物の経皮吸収性を高め、患部と水分との直接の接触を防止することによって患部の薬効を高めると同時に患部の副作用(かぶれ、発赤、水泡等)を予防する。
基剤単独でも膏体を薄く塗布した皮膚上に皮膜を形成することによって皮膚の保湿性を維持しつつ皮膚自体をガードし、衣服や草木等による擦過といった物理的刺激から皮膚を守る作用を発揮する。つまり形成被膜自体が強靭な第二の人工角質層にもなり得る。このため、塗布した薬物を被膜で被覆することによって入浴やシャワーによる薬剤の流出を防止することができ、その効果の持続性が期待できる。更に、水を介しての第三者への感染と違和感を解消する。
なお、本発明はロジンを単独添加することを特徴するものであるが、ロジンに変えてロジンと同等のロジン酸や松脂、及びこれらを混合したものを用いてもよい。しかし、その作用・効果はロジンの単独使用の場合に比べて多少劣る。
このように、本発明の特徴を損なうものでなければ、上述した実施例に限定されるものでないことは勿論である。
In other words, when a drug substance is included in the base material, it improves the percutaneous absorbability to the affected area, enhances the local therapeutic effect, and further protects the affected area with a film, so that it can be physically and chemically applied from the outside. Prevents irritation and bacterial infection. After application to the skin, the solvent evaporates and forms a transparent or translucent film on the affected area's skin to seal the affected area. Increase the efficacy of the affected area by preventing direct contact between the affected area and water, and at the same time, prevent side effects (rash, redness, blistering, etc.) of the affected area.
Even with the base alone, it forms a film on the skin where the plaster is thinly applied to protect the skin itself while maintaining the moisture retention of the skin, and protects the skin from physical irritation such as rubbing with clothes and plants. To do. That is, the formed coating itself can be a tough second artificial stratum corneum. For this reason, by covering the applied drug with a film, it is possible to prevent the outflow of the drug due to bathing or showering, and the sustainability of the effect can be expected. Furthermore, the infection and discomfort to third parties via water are eliminated.
In addition, although this invention is characterized by adding rosin alone, you may use rosin acid equivalent to rosin, rosin, and what mixed these instead of rosin. However, its action and effect are somewhat inferior compared to the case of using rosin alone.
Thus, it goes without saying that the present invention is not limited to the above-described embodiments as long as the features of the present invention are not impaired.
本発明の実施例の被膜形成型製剤は皮膚上にフィルムを形成するので、薬物を含有しない製剤としても、皮膚の角質層の役割(外部からの物理的化学的浸透に対する防御)と発汗の制御と基剤成分(エチルアルコール等)による殺菌・消毒作用により体臭(汗臭)を予防することも可能であり、保湿剤の一種以上を含有させ、皮膜形成後の皮膚の保湿性を改善することもでき、また、肌が露出する場合には実施例の被膜形成型製剤を肌に塗布することで、蚊や虫が肌を刺すことができないので、虫さされの防護剤として用いることもできる。この場合には、ロジン自体に蚊や虫に対する忌避効果があるので、更に有効である。
また、スポーツ時の手に、湿布することによって、形成被覆が発汗を抑え、臭い発生を抑制しつつ、手足の滑り止め効果を発揮し、更に、皮膚の強靱性を高めることによって、手の平や足底をガードし、スポーツ障害を防止し成績向上につなげる可能性もある。
Since the film-forming preparation of the embodiment of the present invention forms a film on the skin, the role of the stratum corneum of the skin (protection against physical and chemical penetration from the outside) and the control of sweating can be achieved even as a preparation containing no drug. It is possible to prevent body odor (sweat odor) by sterilizing and disinfecting with the base ingredients (ethyl alcohol, etc.), and to contain one or more moisturizers to improve the moisture retention of the skin after film formation In addition, when the skin is exposed, the film-forming preparation of the example can be applied to the skin, so that mosquitoes and insects cannot pierce the skin, and can be used as an insect bite protective agent. . In this case, the rosin itself is more effective because it has a repellent effect against mosquitoes and insects.
In addition, by applying a poultice to the hands during sports, the formed coating suppresses sweating, suppresses the generation of odors, exhibits an anti-slip effect on the limbs, and further enhances the toughness of the skin, thereby improving the palms and feet of the hands. Guarding the bottom may prevent sports problems and improve performance.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009083355A JP5396125B2 (en) | 2009-03-30 | 2009-03-30 | Film-forming formulation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009083355A JP5396125B2 (en) | 2009-03-30 | 2009-03-30 | Film-forming formulation |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010235471A JP2010235471A (en) | 2010-10-21 |
JP5396125B2 true JP5396125B2 (en) | 2014-01-22 |
Family
ID=43090160
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009083355A Expired - Fee Related JP5396125B2 (en) | 2009-03-30 | 2009-03-30 | Film-forming formulation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5396125B2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2626089A1 (en) | 2012-02-10 | 2013-08-14 | LTS LOHMANN Therapie-Systeme AG | Liquid preparation for covering or treating skin sections |
JP2014122173A (en) * | 2012-12-20 | 2014-07-03 | Nippon Kenko Kagaku Kenkyu Center:Kk | Insecticidal and repelling preparation forming film |
WO2014104149A1 (en) * | 2012-12-28 | 2014-07-03 | 大正製薬株式会社 | Preparation for application to skin |
KR20230129619A (en) | 2013-08-21 | 2023-09-08 | 베리카 파마슈티컬스 인크. | Compositions, methods and systems for the treatment of cutaneous disorders |
AU2015364524A1 (en) | 2014-12-17 | 2017-07-13 | Verrica Pharmaceuticals, Inc. | Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives |
WO2016118633A1 (en) | 2015-01-20 | 2016-07-28 | Verrica Pharmaceuticals, Inc. | Quantification and preparation of pharmaceutical grade cantharidin |
JP6775976B2 (en) * | 2016-03-18 | 2020-10-28 | 小林製薬株式会社 | Topical preparation for reducing skin friction |
JP2018000390A (en) * | 2016-06-29 | 2018-01-11 | 有限会社日本健康科学研究センター | Acidic artificial keratin-forming preparation |
JP7280870B2 (en) | 2017-06-06 | 2023-05-24 | ヴェリカ ファーマシューティカルズ インコーポレーテッド | Treatment of skin disorders |
USD900312S1 (en) | 2017-06-15 | 2020-10-27 | Verrica Pharmaceuticals, Inc. | Applicator |
JP2019156763A (en) * | 2018-03-13 | 2019-09-19 | 有限会社日本健康科学研究センター | Waterproof coating formulation |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5878663A (en) * | 1981-11-04 | 1983-05-12 | 埼玉第一製薬株式会社 | Rapid drying film forming base agent |
JPH0637386B2 (en) * | 1985-12-13 | 1994-05-18 | ライオン株式会社 | Retention type base for oral cavity |
JPH0632733A (en) * | 1992-05-18 | 1994-02-08 | Hisamitsu Pharmaceut Co Inc | Patch for assaying atopic dermatitis and method for testing atopic dermatitis |
JP3359391B2 (en) * | 1993-09-07 | 2002-12-24 | 久光製薬株式会社 | Patch for tumor test and test method using the same |
JPH1095726A (en) * | 1996-09-20 | 1998-04-14 | Seiwa Kasei:Kk | Cosmetic base |
JPH1135919A (en) * | 1997-07-25 | 1999-02-09 | Daicel Chem Ind Ltd | Water soluble hot melt adhesive with excellent high speed adhesion |
JP2003040722A (en) * | 2001-07-23 | 2003-02-13 | Kuraray Co Ltd | Bleached tooth coating composition and coating method |
JP2006282952A (en) * | 2005-04-05 | 2006-10-19 | Aica Kogyo Co Ltd | Aqueous honeymoon adhesive |
WO2008050491A1 (en) * | 2006-10-24 | 2008-05-02 | Japan Health Science Research Center.Ltd. | Film preparation for forming film on skin |
JP5074091B2 (en) * | 2007-05-07 | 2012-11-14 | 有限会社日本健康科学研究センター | Film repellent to prevent mosquito bites |
-
2009
- 2009-03-30 JP JP2009083355A patent/JP5396125B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2010235471A (en) | 2010-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5396125B2 (en) | Film-forming formulation | |
AU2006311518B2 (en) | Film-forming resins as a carrier for topical application of pharmacologically active agents | |
US20070196458A1 (en) | Compositions and methods for dermally treating neuropathic pain | |
JP5542665B2 (en) | Matrix-type transdermal administration agent and method for producing the same | |
CN104307032B (en) | A liquid dressing that relieves pain, is antimicrobial, stops bleeding and promotes wound healing | |
Vinklárková et al. | Film wound dressing with local anesthetic based on insoluble carboxymethycellulose matrix | |
CA2850908C (en) | Aqueous antimicrobial composition containing coniferous resin acids | |
WO2009017767A2 (en) | Compositions and methods for dermally treating neuropathy with minoxidil | |
JP5740393B2 (en) | Composition suitable for topical treatment of fungal infections of the skin and nails | |
JP2008501805A (en) | Adhesive skin-forming formulation for skin delivery of drugs and method of using the same | |
JP2009524586A (en) | Compositions and methods for skin treatment of pain | |
CN102427802A (en) | Medicinal cream prepared by using silver sulfadiazine and chitosan and preparation method thereof | |
EP2196197A1 (en) | Antiviral patch | |
JP5074091B2 (en) | Film repellent to prevent mosquito bites | |
CA2717737A1 (en) | Hand sanitizing patch | |
Bakhrushina et al. | Spray Film-Forming systems as promising topical in situ Systems: A review | |
CN101494976A (en) | Compositions and methods for dermally treating pain | |
US20120115812A1 (en) | Surface coatings for skin | |
JP2022522567A (en) | Dermis protectant and carrier | |
US20090317451A1 (en) | Pressure-sensitive adhesive for skin surface and/or transdermal substance delivery | |
KR20110027434A (en) | Composition for forming a water repellent film capable of sustained release of the drug | |
US20150250887A1 (en) | Method of preparing resin tinctures | |
KR101858835B1 (en) | composition of an aerosol formulation for spray band and method for preparing the same | |
US11154542B2 (en) | Nail lacquer composition containing ciclopirox | |
Al-Jarsha et al. | A Review on Film Forming Drug Delivery Systems |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120217 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130823 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130830 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130902 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130918 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20131021 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5396125 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |